-
June 14, 2013
Abbott Labs (ABT) recently announced that it has initiated a randomized controlled study in Japan to evaluate ...
-
June 12, 2013
Bear of the Day: Covidien (COV) - Bear of the Day
-
May 08, 2013
Amgen really needs the pipeline to come through to support this valuation.
-
April 29, 2013
Expectations are the bigger issue for Covidien, as underlying growth is still pretty good on a relative basis.
-
April 17, 2013
Although JNJ reported decent earnings and has some major new drugs lined up - downside risk is definitely still present.
-
February 05, 2013
Mead Johnson seems overvalued for its above-average growth prospects.
-
January 30, 2013
Better-than-expected quarterly results once again guided the S&P 500 and the Dow Jones into the green on Tuesday. ...
-
January 29, 2013
We are in the midst of the fourth quarter earnings season and it is once again time to review the players in the ...
-
January 29, 2013
We are in the midst of the fourth quarter earnings season and it is once again time to review the players in the ...
-
January 28, 2013
Poor reporting and weak margins undermine the potential of Abbott.
-
January 25, 2013
Covidien plc. (COV) reported its adjusted earnings per share of $1.10 for the first quarter of fiscal 2013, 4 cents ...
-
January 23, 2013
Abbott Labs (ABT) reported fourth quarter 2012 earnings of $1.51 per share, a penny ahead of the Zacks Consensus ...
-
January 09, 2013
Abbott Laboratories (ABT) recently announced that its Absorb Bioresorbable Vascular Scaffold (BVS) device has moved ...
-
January 08, 2013
Investor apprehensions surrounding fourth-quarter earnings dragged benchmarks into negative territory on Monday. ...
-
January 07, 2013
Auxilium Pharmaceuticals, Inc. (AUXL) and Xstelos Holdings, Inc. (XTLS) recently received a notice from Upsher-Smith ...
-
January 04, 2013
January 2 was the first day of trading for the pharmaceutical spin-off.
-
January 03, 2013
Coronado Biosciences (CNDO) recently amended its existing license and supply agreements with Ovamed GmbH. Coronado ...
-
January 03, 2013
Abbott Laboratories (ABT) recently announced that the company has separated its research-based pharmaceuticals ...
-
December 21, 2012
Following a strong first quarter result and an encouraging guidance, we upgrade our recommendation on Myriad ...
-
December 19, 2012
Actelion (ALIOF) recently announced positive results from a phase II study on its S1P1 modulator, ponesimod. ...
